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Extracellular matrix mineralization is an essential physiologic process in bone, teeth, and
hypertrophic cartilage. Matrix Gla protein (MGP), an inhibitor of mineralization, is expressed
by chondrocytes and vascular smooth muscle cells to inhibit calcification of those soft
tissues. Tibial dyschondroplasia (TD), a skeletal abnormality apparent as a plug of non-
vascularized, non-mineralized, white opaque cartilage in the tibial growth plate of avian
species can serve as a good model for studying process and genes involved in matrix
mineralization and calcification. In this work, we studied the involvement of MGP in the
development ofTD, as well as in the processes of spontaneous and induced recovery from
this syndrome. First, we found that during normal bone development, MGP is expressed
in specific time and locations, starting from wide-spread expression in the yet un-ossified
diaphysis during embryonic development, to specific expression in hypertrophic chondro-
cytes adjacent to the chondro-osseous junction and the secondary ossification center just
prior to calcification. In addition, we show that MGP is not expressed in the impaired TD
lesion, however when the lesion begins to heal, it strongly express MGP prior to its calcifi-
cation. Moreover, we show that when calcification is inhibited, a gap is formed between the
expression zones of MGP and BMP2 and that this gap is closed during the healing process.
To conclude, we suggest that MGP, directly or through interaction with BMP2, plays a role
as ossification regulator that acts prior to ossification, rather then simple inhibitor.
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INTRODUCTION
Longitudinal growth takes place at the growth plates containing
cartilage cells (chondrocytes) at different stages of differentiation,
which are gradually replaced by bone tissue through endochon-
dral ossification process (Hunziker, 1994). Chondrocytes within
the growth plate can be divided into different anatomic zones
according to their morphology, components of the extracellu-
lar matrix (ECM), enzymes activity, and expression of growth
factors and receptors. The resting zone, in which the ratio of
ECM to cell volume is high and the cells are in a relatively quies-
cent state; the proliferative zone, in which the chondrocytes have
a flattened-spheroid shape and arranged into columns, forming
dense structures parallel to the bone’s longitudinal axis, and pro-
duce matrix rich in type II collagen (Col II); the pre-hypertrophic
zone in which chondrocytes cease to proliferate and begin to
undergo differentiation; the hypertrophic zone containing fully
differentiated chondrocytes with large cellular volume, matrix rich
in type X collagen (Col X), and alkaline phosphatase (ALP) activ-
ity; the ossification zone, which is invaded by blood vessels, the
ECM undergo mineralization, and replaced by bone tissue (Olsen
et al., 2000; Kronenberg, 2003).
Extracellular matrix mineralization is an essential physiologic
process in bone, teeth, and hypertrophic cartilage. To date, few
proteins acting as regulators of ECM mineralization have been
identified; all are considered as mineralization inhibitors. These
include: Ank, a protein controlling export of pyrophosphate
(a small molecule that itself inhibits ECM mineralization); NPPS,
an ectoenzyme generating pyrophosphate; and matrix gla pro-
tein (MGP) (Jahnen-Dechent et al., 1997; Okawa et al., 1998;
Nakamura et al., 1999; Ho et al., 2000; Schafer, 2003).
Matrix Gla protein is expressed in chondrocytes and in vascular
smooth muscle cells, two cell types that produce an un-calcified
ECM (Luo et al., 1997). It contains gla (γ-carboxylated glutamic
acid) residues (Pudota et al., 2000; Bandyopadhyay et al., 2002),
and a posttranslational modification confers the protein high
affinity for hydroxyapatite crystals which are the major mineral
crystal present in mineralized ECMs (Romberg et al., 1986; Roy
and Nishimoto, 2002). This enables MGP to bind mineral crys-
tals, thereby actively inhibiting calcification of the soft tissues in
which it is expressed. MGP-deficient mice develop spontaneous
calcification of arteries and cartilage, and exhibit inappropriate
calcification of the growth plate, which eventually leads to short
stature, osteopenia, and fractures (Luo et al., 1997).
The avian growth plate, due to its unique feature, can serve as
a model to study growth-plate mineralization and ossification. In
this plate the chondrocytes columns are higher,denser, and less ori-
ented than in mammals, hence it is longer and more vascularized
than the mammalian one (Leach and Gay, 1987; Hunziker, 1994).
Moreover, disruptions in calcification of the growth plate can lead
to skeletal abnormalities such as tibial dyschondroplasia (TD) and
rickets, two disorders causing bone fractures and deformities, and
can serve as an exceptional model to study calcification-related
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issues. Aside for the model benefits that enable to study the role of
various genes and proteins in the calcification process, these species
differences may influence the results, serving on one hand as gen-
eral developmental model while also may reflect avian specific
phenomenon.
Tibial dyschondroplasia is one of the most prevalent skeletal
abnormalities observed in avian species that have been geneti-
cally selected for rapid growth. It was first described by Leach and
Nesheim (1965) as an apparent plug of non-vascularized, non-
mineralized, white opaque cartilage in the tibial growth plate.
Although the cause of TD is still not known, several theories
were suggested to explain its’ etiology including: inhibition in the
differentiation of pre-hypertrophic chondrocytes to hypertrophic
(Leach and Gay, 1987; Farquharson et al., 1992; Farquharson and
Jefferies, 2000; Praul et al., 2000; Webster et al., 2003), secretion
of immature cartilage resistant to resorption and vascularization
(Orth and Cook, 1994); defects in the synthesis and secretion of
MMPs resulting in lesser ECM degradation and fewer blood vessels
penetration into the growth plate (Simsa et al., 2007b; Hasky-
Negev et al., 2008; Dan et al., 2009), and endoplasmic reticulum
stress in growth plate chondrocytes that activates autophagy as
a cell survival mechanism (Leach and Monsonego-Ornan, 2007).
Spontaneous recovery from TD was recorded in poultry; however
no attempt was made to understand the mechanism underlying
this healing process.
In this work we used a model for induction and recovery from
TD. We found that MGP is expressed in the TD lesion during
the healing process, and that it is expressed in close proximity to
BMP2 in the healing lesion but not in the control growth plate.
The results obtained in this study suggest that MGP is not only
an inhibitor but rather a regulator of cartilage calcification in the
growth plate.
MATERIALS AND METHODS
ANIMALS AND INDUCTION OF TD AND RICKETS
One-day-old Cobb strain broiler chicks (n= 400) were obtained
from a commercial hatchery (Brown Hatcheries, Hod Hasharon,
Israel). Chicks were divided into two groups: control group
received standard diet according to National Research Council
(NRC) recommendations (n= 160) and “thiram” group which
received the same diet plus 50 mg/kg of thiram (n= 240). After
7 days, 80 birds from the thiram group were randomly picked and
FIGURE 1 | Effect of thiram and thiram-removal onTD incidence in
broilers. (A) Four hundred chicks were divided into two groups: control group
received standard diet (n=160) and thiram group which received the same diet
containing 50 mg/kg of thiram (n=240). After 7 days, 80 birds from the thiram
group were picked randomly and transferred to a non-thiram diet for further
7 days (recovery). At days 3, 7, 10, and 14, 40 chicks from each group were
scarified. All tibial growth plates were dissected and scored for TD severity.
(B) Relative percentages of each score. (C) Average score for each group.
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transferred to a non-thiram diet (Figure 1). All groups were raised
for total 14 days under the recommended temperature regime; all
groups had free access to food and water. Rickets was induced in
1-day-old Cobb strain broiler chicks (n= 50) by supplying a diet
with no vitamin D and housing in dark conditions for 15 days. All
procedures were approved by the Animal Care Welfare Committee
of the ARO’s Volcani Center.
VALIDATION OF TD INDUCTION AND RECOVERY
On days 3, 7, 10, and 14, the number of lame birds was counted
in each group. Forty birds from each group were sacrificed by
cervical dislocation; proximal growth plates of the right and
left tibia were shaved longitudinally to determine the incidence
and severity of TD. The severity was scored subjectively as: 0,
healthy growth plate; 1, recognizable cartilage plaque; 2, plaque
covering up to 20% of the longitudinal section; 3, plaque cov-
ering up to 50% of the longitudinal section; 4, plaque cov-
ering up to 80% of the longitudinal section. Whole growth
plates were collected and fixed in 4% PFA, or frozen for further
analysis.
RNA ISOLATION AND REVERSE TRANSCRIPTION
For RNA extraction, proximal tibial growth plates were isolated
and submerged in RNeasy Maxi kit (Qiagen, Hilden, Germany)
according to the manufacturer’s protocol. Total RNA (1µg) was
reverse-transcribed in a final volume of 20µl with the Reverse-RT
kit (ABgene, Epsom, Surrey, UK) using oligo-dT/hexamer primers,
at reaction temperatures of 42˚C for 1 h and 75˚C for 10 min.
REAL-TIME PCR
cDNA (1µl) was used for real-time PCR using the fluorescent
dye SYBR Green I (Absolute QPCR SYBR Green Mix, ABgene)
to monitor DNA synthesis using specific primers for MGP and
BMP2:
MGP – forward: CAGGAGAGGATCAGGGAACG backward:
AAGCAGCAGGATAGCCATGG
BMP2 – forward: ACAGTTGCAAAAGGCATCCG backward:
CGGAAAAGGACATTCCCCAT
The PCR was carried out in the ABI Prism 7300 system (Applied
Biosystems, Foster City, CA, USA) using the following cycling pro-
tocol: a 95˚C denaturation step for 15 min followed by 40 cycles of
95˚C denaturation (15 s), 60˚C annealing (30 s), and 72˚C exten-
sion (30 s). Gene expression was normalized to the housekeeping
gene Gallus gallus ribosomal 18S. The amplified PCR product was
analyzed with ABI Prism 7300 software (Applied Biosystems).
At the end of the real-time PCR, a melting curve was deter-
mined to verify the presence of a single amplicon (Reich et al.,
2008).
PREPARATION OF PROBES
Probes for in situ hybridization were prepared by PCR amplifi-
cation from cDNA of both chicken growth plates and primary
cultured chondrocytes isolated from the proximal tibial growth
plates using the following primers:
MGP – forward: AATGCGTGCTCTCATCGTC backward:
TCCTCCTCCCAAAATAGTGC
BMP2 – forward: AAGTGGGAAAACAGCACGAC backward:
GATATGGTTGTGGAGGGCTG
Probe sizes ranged from 600 to 800 bp. Products were ligated
into pGEM constructs using the pGEM T Easy kit (Promega,Madi-
son,WI, USA) according to the manufacturer’s protocol, to be used
as probes for in situ hybridization. Restriction enzymes were used
to create sense or antisense probes (Tong et al., 2003; Simsa et al.,
2007a).
HISTOLOGICAL STAINING AND IN SITU HYBRIDIZATION OF
GROWTH-PLATE SECTIONS
Growth plates were fixed overnight in 4% paraformaldehyde
(Sigma) in PBS at 4˚C. The samples were dehydrated in graded
ethanol solutions, cleared in chloroform, embedded in Paraplast,
and 5-µm sections were prepared. Alcian-blue and Von-Kossa
(Ab&Vk) staining were performed with 0.6% Alcian-blue 8 GX
in 70% ethanol and with 2% silver nitrate exposed to sunlight.
Hybridizations were performed as described by Reich et al. (2005).
The sections were deparaffinized in xylene, rehydrated through
a graded series of ethanol solutions, rinsed in distilled water
(5 min), and incubated in 2× SSC at 55˚C for 30 min. The sections
were then rinsed in distilled water and treated with proteinase K
(10µg/ml in 0.2˚M Tris-HCl, 5 mM EDTA, pH 7.5) for 10 min.
After digestion, slides were rinsed with distilled water, fixed in
10% formaldehyde in PBS, blocked in 0.2% glycine, rinsed in
distilled water, rapidly dehydrated through graded ethanol solu-
tions, and air-dried for several hours. The sections were then
hybridized with 35S-labeled probes (10 ng) for MGP, or BMP2,
(Reich et al., 2005). Radioactive signals were intensified using
emulsion (Eastman Kodak Company, Rochester, NY, USA): the
sections were incubated with the emulsion solution for 1 month,
in the dark, at room temperature. No signal was observed in any of
the hybridizations with sense probes, which were used as controls.
RESULTS
THIRAM-INDUCED TD LESION IS REVERSIBLE THROUGH A RECOVERY
PROCESS
To induce TD, chicks were fed with thiram-enriched diet (thi-
ram group) according to well established protocol (Rath et al.,
2004; Hasky-Negev et al., 2008). After 1 week, half of the chicks
in this group were picked randomly and the thiram-enriched
diet was replaced to normal diet for another week in order to
obtain a recovery process, while the other half continued to receive
thiram (Figure 1A). During the 2-weeks experimental period,
growth plates were collected for TD scoring, RNA preparation,
and histological analysis.
The results of TD scoring (Figure 1B), demonstrate that after
3 days of thiram consumption no growth plates were affected by
TD. However, on the 7th day, 83% of the legs had TD of any sever-
ity. After 10 days the percentage of disordered growth plates was
94%, and after 2 weeks in the thiram group it was 81% (due to
spontaneous recovery). There were no cases of TD in the con-
trol group during all the experiment. The data in Figure 1C
presents the average score per group. This, together with the data
in Figure 1B, demonstrates the worsening of the lesion with the
progression of the experiment. On day 7, the average score for
the thiram group was 1.7± 0.09 as only 25% of legs had severe
TD lesions (scored 3 and 4) while after 10 days the average score
was 2.53± 0.11 resulting from 60% legs with severe lesions. The
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recovery group showed lower levels of TD occurrence and severity
of lesions, already after 3 days of recovery (day 10), at which the
average score was 1.38± 0.12, representing 18% of the legs with
severe lesions (score 3 and 4) and 50% with milder TD (score 1
and 2). This was further improved after 7 days of recovery (day
14) at which the average score was 0.47± 0.13 as no more than
7% of the legs had severe lesions and 20% had milder TD, while
the average score of the thiram group at that time was 2.41± 0.12.
The presented data validates the quality and the stability of our
model.
MGP IS EXPRESSED IN A PRE-OSSIFICATION MANNER DURING BONE
DEVELOPMENT
In order to find genes which are involved in the development and
recovery of TD, mRNAs were extracted from growth plates of
each group, and tested for differentially expressed genes between
the groups. One of those genes was MGP, a vitamin K-dependent
matrix calcification inhibitor (Luo et al., 1997).
Up until now, localization of MGP transcripts in the tibial
growth plate was described only in a 12-days-old chicken embryo
(e12) (Yagami et al., 1999), however detailed characterization of
MGP expression during the development of the chicken’s growth
plate has not been published. For this purpose, we applied an
in situ hybridization analysis on the proximal tibia of e14, e18, 1,
3, 7, 8, 12, and 14 days old chickens. Ab&Vk staining, in which
cartilaginous substance stains blue and minerals stains black, were
performed in order to localize MGP expression (Figures 2 and 3).
Up to the age of 3 days after hatching there are still vast un-ossified
cartilaginous regions in the developing bone (Figure 2A). In those
stages MGP is expressed throughout the pre-ossified cartilage and
around blood vessels of the epiphysis (Figure 2B). From the 7th
day the metaphysis is fully ossified and a defined growth plate had
already formed (Dan et al., 2009). Detailed investigation of MGP’s
expression on this day reveals expression in cells surrounding the
blood vessels of the proliferative zone but not in proliferative
chondrocytes (Figure 2C – PZ), while in the hypertrophic zone
the opposite phenomena is observed – hypertrophic chondrocytes
strongly express MGP, except for those adjacent the blood vessels
(Figure 2C – HZ). The expression of MGP is particularly observed
near the chondro-osseous junction. No MGP expression was seen
in the pre-hypertrophic zone (Figure 2C – PHZ). In the secondary
ossification center (SOC), MGP’s expression pattern was similar
to that seen in the proliferative zone, meaning expression in cells
located in close proximity to the blood vessels (Figure 2C – SOC).
This pattern characterizes MGP expression in all further develop-
mental stages we checked (Figures 3B–D). These results suggest
FIGURE 2 | Matrix Gla protein expression in the chick’s growth plate
during development. (A) Alcian-blue & Von-Kossa staining of whole growth
plate at the age of 3 days. (B) Chick growth plates from embryonic days 14
and 18 and at the ages of 1, 3, and 7 days were processed as described in
Section “Materials and Methods” and subjected to in situ hybridization with
35S-labeled riboprobes of the avian MGP (×7.5). (C) Expression of MGP in the
growth plate of 7 days old chick. PZ, proliferative zone – MGP expression
around blood vessels in the proliferative zone; HZ, hypertrophic
zone – expression in hypertrophic chondrocytes; PHZ, pre-hypertrophic
zone – no expression in the pre-hypertrophic zone; SOC, secondary
ossification center – MGP expression around epiphyseal blood vessels. (D)
MGP expression during the formation of the secondary ossification center .
On days 3 and 8 (3d and 8d) MGP is expressed prior to ossification in cells
surrounding the blood vessels of the epiphysis. On 3 and 4 weeks (3w and
4w), once ossification takes place, MGP expression in the margins of the
secondary ossification center (arrows). (×10).
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that during normal bone development MGP is expressed in areas
that are about to undergo ossification immediately prior to its
initiation.
The expression pattern of MGP, preceding the ossification
process is demonstrated very clearly during the formation of
the SOC. The SOC is formed by endochondral ossification, i.e.,
its development begins by the formation of a cartilage template
which is later replaced by bone (Rivas and Shapiro, 2002). In early
stages of the SOC development (days 3 and 8), prior to its ossifi-
cation, when it is still occupied by cartilage, MGP is expressed
throughout the epiphysis in the place where ossification later
occurs (Figure 2D). Once ossification takes place (3 and 4 weeks),
MGP expression diminishes from the center and accompanies the
margins of the SOC (Figure 2D).
MGP EXPRESSION IS INCREASED WITHIN THE HEALING TD LESION
AND PRECEDES THE OSSIFICATION PROCESS
Next we were interested to understand whether MGP is involved
in the development of TD and the process of recovery from it.
For that purpose we quantified MGP’s expression in growth plates
isolated from the three experimental groups by real-time PCR. As
expected, on day 3, when the lesion is only initiating, MGP expres-
sion was not different between the thiram and the control groups
(Figure 3A). However, on day 10, when 60% of the legs in the
thiram group have severe TD lesions (Figure 1B), MGP expres-
sion is almost 2.5 times higher in the thiram-fed chicks compared
to the control (Figure 3A), suggesting that MGP is involved in
the inhibited calcification of the TD lesion. Interestingly, in the
recovery group, MGP expression level is not different from the
control (Figure 3A), meaning that no more than 3 days after the
removal of thiram, MGP expression returns to normal, allowing
ossification, and thereby recovery of the lesion.
Since prior to this study MGP had never been associated with
TD, we further established its involvement in the development
and recovery from this syndrome, by studying MGP’s expression
in sequential sections stained with Ab&Vk applied on a set of lon-
gitudinal sections of proximal tibias isolated from the different
groups (Figures 3B–D). On the 8th day (Figure 3B), most of the
metaphysis is ossified, both in the control and thiram groups. Cor-
respondingly, a drastic reduction in MGP expression is observed
compared to day 3 (Figure 2B). This reduction is expected since
MGP’s role is to inhibit calcification in non-calcified tissues (i.e.,
cartilage), once the tissue had gone calcification, MGP is no longer
needed. On this day, MGP expression is found in the proximity
of blood vessels in the epiphysis and proliferative zone, as well as
in the hypertrophic chondrocytes mainly those that are close to
the chondro-osseous junction, as shown in Figure 2C. In the thi-
ram group, the TD lesion is already apparent on this day. MGP
expression is not seen in the lesion area, but it appears below the
lesion, where calcification takes place (Figure 3B). The recovery
process is only initiating (24 h), with strong MGP expression in the
place soon to be ossified (Figure 3B). On the 12th day the lesion
is wide-spread over the metaphysis containing dense opaque car-
tilage as observed by Alcian-blue staining. Spontaneous recovery
process begins at the margin of the lesion characterized by par-
tial resorbtion and ossification seen as limited Von-Kossa staining
surrounded by cartilaginous material (Figure 3C pointed with
arrowhead). MGP is not expressed in the dense lesion but it is
highly expressed in the area undergoing recovery (Figure 3C lower
panel pointed with arrowhead). In the recovery group, at this time
point, the recovery process is in its peak (Figure 3C); a lesion is
still observed, however it is much smaller than the lesion in the
thiram group. The Von-Kossa staining, which replaced the Alcian-
blue staining, together with the evident blood vessels penetrating
the growth plate (Figure 3C), point that the lesion is undergoing
rapid resorption and ossification. Similar to the observed during
the spontaneous recovery, here we also see that MGP is absent
from the opaque lesion area but it reappears at the healing site
(Figure 3C). On day 14, an interesting phenomena is observed,
MGP which up till now was absent from the lesion, is widely
expressed within the lesion of the thiram group (Figure 3D). On
this day, massive spontaneous recovery occurs in the thiram group,
revealed by the ossifying cartilage (Von-Kossa staining) inside the
lesion (Figure 3D), and blood vessels penetration into it. Note
that MGP is particularly expressed in areas that show signs of
healing and resorption (Figure 3D pointed with arrowhead). In
the recovery group, the lesion is completely ossified by this day, and
resembles the control, and so is MGP expression which is hardly
detectable in this group (Figure 3D).
For comparisons, we studied the expression of MGP in rachitic
growth plates as another model of calcification impedance, but
unlike the TD lesion, it does not go a recovery process. Rickets was
induced by vitamin D deficiency and housing in dark conditions
(Hasky-Negev et al., 2008). The rachitic growth plates at the ages
of 8 (Figure 3E) and 15 days (Figure 3F) demonstrated the typical
phenotype of expanded growth plate due to inhibition of mineral-
ization. MGP was expressed along the chondro-osseous junction,
but not within the rachitic lesion (Figures 3E,F), demonstrating
that MGP is expressed in remodeled cartilaginous lesions but not
in persistence cartilage lesion that does not resolved. This strength-
ens our suggestion that MGP plays a significant role in regulating
the calcification process in a wider sense than inhibition through
calcium binding.
Higher magnifications demonstrate thiram’s effect on cell mor-
phology and MGP expression (Figure 4A). In the proliferative
zone cell morphology appears normal (Figure 4A), however MGP
expression in the cells surrounding the vessels is lower in the
thiram group (Figure 4A – BV in proliferative zone). In the pre-
hypertrophic (Figure 4A) and hypertrophic zones (Figure 4A),
cell morphology and spatial organization is dramatically changed
following thiram treatment; the normal well organized structure
of cells become disoriented and scattered with abnormal cell mor-
phology and scattered MGP expression (Figure 4A). Moreover,
as expected, the TD lesion is clear of blood vessels (Figure 4A
lower panel – left image). Vessels do not penetrate into the lesion
but rather stop at its border creating a truncated shaped vessel
(Hasky-Negev et al., 2008). Figure 4A lower panel – right image
demonstrates an impaired area with no blood vessels and no MGP
expression, and next to it, a healed area in which blood had already
penetrated to and MGP is expressed (Figure 4A lower panel – right
image).
During the recovery process (whether spontaneous or delib-
erate) MGP is expressed in areas that are about to be calci-
fied (Figures 3C,D). The recovery is not a homogenous process
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FIGURE 3 | Matrix Gla protein expression in the processes ofTD
development and recovery. (A) RNA was extracted from growth plates of
the control, thiram, or recovery groups on days 3, 7, and 10. MGP expression
was measured by real-time PCR analysis. (B–D)Whole growth plates from
control, thiram, or recovery groups on days 8 (B), 12 (C), and 14 (D) were
stained with Alcian-blue & Von-kossa (upper panels) or processed as
described in Section “Materials and Methods” and subjected to in situ
hybridization with 35S-labeled riboprobes of the avian MGP (lower panels;
×7.5). (B) No MGP expression in the lesion area. (C,D) Arrows pointing MGP
expression in areas that show signs of healing and resorption. TD, tibial
dyschondroplasia. (E,F) Rickets was induced by vitamin D deficiency. MGP
expression was studied on days 8 (E) and 15 (F) by in situ hybridization. No
MGP expression was found in the rachitic lesion (marked by an arrow), its
expression is “pushed” to the new chondro-osseous junction.
throughout the lesion; different stages of healing are noticed in the
recovered growth plate. Figure 4B shows changes in MGP expres-
sion demonstrating those stages. The stages are marked I, the most
impaired, to IV, the most healed. Figure 4BI demonstrates an area
where the lesion is still wide-spread based on the cells abnormal
morphology and the few blood vessels which are truncated at the
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FIGURE 4 |Thiram effects cell morphology and MGP expression in the growth plate. (A)The effect of thiram on MGP expression in the proliferative zone,
around blood vessels in the proliferative zone, pre-hypertrophic, and hypertrophic zones. (B) Stages of the recovery process. I, most impaired; IV, most healed.
lesion border. No MGP expression is found in the impaired area.
On the left side of the image scattered MGP expression start to
appear. Figure 4BII was taken from an area at the lesion border.
More blood vessels are observed, but those are still not organized,
and more cells express MGP. The area in Figure 4BIII is almost
healed; normal-appearing blood vessels are found in this area and
strong MGP expression is observed in hypertrophic cells before
calcification. Figure 4BIV represents a fully healed growth plate;
metaphyseal blood vessels penetrate up to the pre-hypertrophic
zone and MGP expression is strong in the hypertrophic zone in a
similar way to the control growth plates.
Our results demonstrate that MGP is not expressed randomly
by various cells in non-calcified tissues; on the contrary it has a
specific timing and pattern of expression. Based on these results
we suggest that MGP is not merely a calcification inhibitor, it is
expressed prior to ossification and might regulate the initiation of
the calcification process.
PROXIMITY BETWEEN MGP AND BMP2 EXPRESSION ZONES IN THE
GROWTH PLATE DURING HEALING
Back in the 1980s, when BMP was first discovered by Kawa-
mura and Urist (1988), they reported it had a tight association
with MGP, and suggested that MGP could influence the delivery
of BMP to target cells through formation of a MGP-Ca2+-BMP
aggregate, and more recent studies have supported this hypothesis
(Bostrom et al., 2001; Sweatt et al., 2003). In order to check
whether such interaction is probable in the avian growth plate,
we studied BMP2 expression in different developmental stages of
the growth plate as well as in the TD lesion and during recov-
ery from TD (Figure 5A). Hybridizations from days 3, 7, and
10 show BMP2 expression does not change during development,
and is exclusively expressed by pre-hypertrophic chondrocytes
(transition zone, TZ) in all groups (Figures 5A,B). Moreover,
BMP2 expression is not influenced by thiram or thiram-removal
(Figure 5A – 10d).
To further explore possible interaction and regulation of BMP2
by MGP, we studied the co-localization of MGP (green) and BMP2
(purple) transcripts in the growth plates (Figure 5C). On day 8, the
control growth plates demonstrated a thin line of BMP2 expres-
sion in the pre-hypertrophic zone, and MGP expression in the
pre-ossified chondro-osseous junction. In the thiram group, MGP
expression was pushed to the lesion boundaries opening a large
gap between BMP2 and MGP expression zones. Interestingly, in
the recovery group, with the initiation of the recovery process,
this gap was closed and the expression zones of BMP2 and MGP
were in close proximity again (Figure 5C – 8d). Same pattern was
observed on day 10 in the recovered growth plates, with reduced
gap between MGP and BMP2 expression (Figure 5C – 10d). On
day 14, BMP2 expression is not changed and MGP expression
is almost vanished from the control group. In the thiram group
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FIGURE 5 | Proximity between the expression zones of BMP2 and MGP
in the growth plate.Whole growth plates were processed as described in
Section “Materials and Methods” and subjected to in situ hybridization
with 35S-labeled riboprobes of the avian BMP2 or MGP. (A) BMP2
expression on days 3, 7, and 10 is restricted to the pre-hypertrophic
(transition zone). BMP2 expression is not influenced by thiram or recovery
(×7.5). (B) BMP2 expression in the transition zone (TZ). Bright field (×100).
(C) Overlap of MGP (green) and BMP2 (purple) expression in control,
thiram, and recovery (×7.5). White line in the upper panel demonstrates the
gap formed between the expression zones of these two genes in the
thiram group compared with the control.
very interesting phenomena is observed, the cells in the lesion,
which go spontaneous recovery, vastly express MGP, closing com-
pletely the gap between the expression zones of BMP2 and MGP
which almost overlap. In the recovery group, in which by now
the lesion had recovered completely, MGP expression is hardly
detected (Figure 5C – 14d).
These results, although descriptive, suggest that close proximity
between MGP and BMP2 is essential for normal ossification. When
a gap is formed between BMP2 and MGP expression zones the ossi-
fication process is slow down, and vice versa – during the recovery
process, when the gap is reduced ossification is accelerated. This
reduced gap brings BMP2 and MGP to close proximity and enable
an interaction between their gene products. These results raise the
speculation that MGP has a dual role in the growth plate, both, as
calcification regulator and, as a modulator of BMP.
DISCUSSION
Ossification inhibition might be one of the mechanisms leading
to the development of the characteristic TD plaque. Up till now a
few candidates have been described as inhibitors of matrix min-
eralization and bone formation (Leach and Monsonego-Ornan,
2007). In this paper we show, for the first time, a link between
one of those inhibitors – MGP and TD. Moreover, we studied the
localization of MGP mRNA during the development of the avian
growth plate and showed that during late stages of embryogene-
sis, MGP is widely expressed in the pre-ossified cartilage anlagen,
but after hatching, its expression gradually diminishes into the
lower hypertrophic zone next to the forming bone as well as in
cells surrounding the blood vessels of the proliferative zone and
the epiphysis. These expression zones are distinguished from those
reported for mouse MGP, in which the gene is expressed mainly
in the proliferating and to much lower extents in the late hyper-
trophic zone of the growth plate (Luo et al., 1997). Furthermore,
we studied MGP expression during the development of the SOC
and found that it is highly expressed in the center of the “future
SOC” and than diminished from the center to the surroundings
of the ossified zone. These results demonstrate that in the avian
growth plate, MGP is expressed specifically in a pre-ossification
manner and suggest that it acts as an ossification regulator, rather
than as a simple ossification inhibitor.
To further address this issue we studied MGP expression in a
model for impaired ossification – the thiram-induced TD lesion
and the process of recovery from TD induced by thiram-removal.
We found that in early stages of TD development (day 8), MGP
is not expressed in the lesion cells and it appears as if “pushed
aside” to the new chondro-osseous junction adjacent to the lesion
boundaries. In later stages (days 12 and 14), in parallel to the
spontaneous recovery process that begins despite continues pres-
ence of thiram, MGP is vastly expressed in the healing lesion.
Interestingly, the cells which express MGP are those found in areas
undergoing healing process, prior to its ossification. MGP seems
to play a significant role in the induced recovery process as well; A
day after the removal of thiram (day 8), when the recovery process
is only initiated, MGP is strongly expressed in the place soon to be
ossified. As the recovery process continues, the lesions are grad-
ually ossified, and MGP expression is found only in the healing
sites but absent from the lesions area. With the completion of the
recovery, MGP expression is gradually reduced. The consistency
between the onsets of recovery (both spontaneous and induced),
the morphology of the lesion (partially vascularized or completely
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opaque), and the specific and timed pattern of MGP expression
is our strongest hint to suggest this new function for MGP as
calcification regulator.
The role of MGP as calcification inhibitor was established by
demonstrating that mice lacking MGP developed spontaneous cal-
cification of arteries and cartilage (Luo et al., 1997). The fact that
calcification occurs at these tissues of all, despite the fact that MGP
is widely expressed in other tissues as well (Wiedemann et al.,
1998), implying that the effect of MGP is developmentally regu-
lated (Yagami et al., 1999). One might argue that the expression
of MGP in the TD lesion acts only as a calcification inhibitor.
However, the fact that it was not expressed in early stages of
the lesion’s development, before it recovers, and in the rachitic
lesion which is not healed, but was strongly expressed prior to a
recovery process, both spontaneous recovery in late stages in the
thiram group and induced recovery after thiram-removal, reveal
that this gene does not mark the lesion specifically and suggest that
it is indeed ossification regulator rather than merely calcification
inhibitor.
The arising complementary issue is how it comes that the lesion
does not undergo calcification? If not MGP, what does hinder
its ossification? We can speculate that the reason is absence of
calcification-inducing agents similar to the case of articular carti-
lage. There are many resemblances between the articular and the
lesion cartilages, in both the prevention of differentiation occurs
due to exogenous signals, since isolated chondrocytes from both
tissues were able to differentiate in culture (Wu et al., 2005). The
lack of differentiation of articular chondrocytes was explained
by the lack of differentiation factors due to poor blood vessel
penetration into this cartilage. It is possible that a similar mech-
anism is responsible for the defective differentiation in the lesion
(Loveridge et al., 1993; Farquharson et al., 1995). Such differen-
tiation factors could be the retinoic acid (RA) known to affect
cartilage development. The fact that RA stimulates not only dif-
ferentiation but also the expression and activity of MMPs in
chondrocytes (Wu et al., 1997; Tong et al., 2003; Simsa et al., 2007b)
further support this option.
Previously, we suggested that the TD lesion can be viewed as
a survival mechanism in response to stress that targets chondro-
cytes in the vicinity of the distal proliferative and TZs (Leach and
Monsonego-Ornan, 2007). Due to close similarity between the
pathological changes associated with TD and those reported by
Tsang et al. (2007) for ER stress and autophagy. The avascular
TZ in the growth plate, where BMP2 is expressed, appears to be
the critical area for the development of these changes. In this
paper we characterized, for the first time, the expression pat-
tern of BMP2 in the avian growth plate. In resemblance to its
expression in mammalian growth plates, BMP2 was localized to
the pre-hypertrophic zone (Yoon and Lyons, 2004), a TZ between
two vasculature systems of the growth plate (the epiphyses and the
metaphyses; Hunt et al., 1979; Howlett et al., 1984). Based on our
results we suggest an optional mechanism by which MGP directly
interacts with BMP2 to generate an inactive complex (Bostrom
et al., 2001; Sweatt et al., 2003). Our findings suggest that regula-
tion of the physical proximity between MGP and BMP2 expression
zones might play a role in calcification inhibition or initiation.
We suggest that when a gap is formed between BMP2 and MGP
expression zones, calcification is inhibited. This formed gap pre-
vents the binding of MGP to BMP2, allowing BMP2’s stimulating
effect on chondrocytes proliferation that could attribute to the
impaired ossification of the TD lesion. On the other hand, during
the recovery process the gap is reduced, bringing MGP and BMP2
to close proximity. The proximity between these genes enhances
the probability for interactions between their products, so that
the binding of MGP to BMP2 inhibits the later effect resulting in
accelerated ossification. It is important to notice that our results
demonstrate the expression patterns of genes rather than pro-
teins which are the active entities. Thus MGP protein and not the
mRNA is the one that regulates ossification or binds BMP. The
rationale to use the mRNA levels rise from the fact that the carti-
laginous growth plate, is packed in its own matrix which trap the
proteins expressed and secreted from chondrocytes. Thus we can
assume that protein localization is parallel to the gene expression
pattern.
To conclude, we show that MGP expression in the avian growth
plate is timely and spatially regulated. We show that it is expressed
specifically before ossification initiation in healthy and impaired
growth plates and suggest that MGP, directly or through interac-
tion with BMP2, plays a role as ossification regulator that acts prior
to ossification.
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